09:48 QUALITY HEALTH<00593> - Announcement & Resumption (9) of 6 months immediately preceding the date of this announcement. No repurchase of securities of the Company has been made by the Company during the period of 12 months immediately preceding the date of this announcement. As at the date of this announcement, the total number of outstanding Warrants are 43,324,376 valued in aggregate HK$108,310,940 carrying the rights to subscribe up to 43,324,376 Shares at the subscription price of HK$2.50 (subject to adjustment) per Share during the period up to and including 13th January 2007, 28.49% of which is held by Wah Cheong. As at the same date, there are outstanding share options granted under the Company's share option scheme entitling the holders to subscribe for 1,627,500 Shares at the exercise price of HK$1.50 during the period from 16th October 2003 to 15th October 2007. Saved as disclosed, there are no outstanding share options, warrants or other securities derivatives convertible into Shares. The Directors would like to remind holders of the Warrants that under the terms and conditions of the instrument constituting the Warrants dated 30 December 2003, the subscription price of the Warrants may need to be adjusted as a result of the Offer subject to the decision of the Board in consultation with SHKIL or the auditors of the Company, depending on the number of acceptances and Shares repurchased under the Offer. If such an adjustment is to be made, details of which will be announced at a later date in due course. SUSPENSION AND RESUMPTION OF TRADING The Shares and Warrants were suspended from trading on the Stock Exchange at 10:12 a.m. on 17th January 2005 pending the release of this announcement. Application has been made to the Stock Exchange for the resumption of trading of such securities from 9:30 a.m. on 25th January 2005. APPOINTMENT OF INDEPENDENT FINANCIAL ADVISER The Directors also announce that the Company has on 18th January 2005 appointed with effect therefrom AMS Corporate Finance Limited, a corporation licensed under the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) for the provision of securities advisory, corporate finance advisory and asset management services, as the independent financial adviser to advise the Independent Board Committee as to whether or not the Offer on its terms is fair and reasonable insofar as the Independent Shareholders are concerned, including but not limited to, formulating a recommendation as to the manner in which the Independent Shareholders should regard the Offer and the Whitewash Waiver and what action, if any, should be taken by them in relation thereto. DEFINITIONS In this announcement, the following expressions have the meanings set out below unless the context otherwise requires: - "Accepting Shareholders" Qualifying Shareholders accepting the Offer "Assured Entitlement" the minimum number of Shares which will be repurchased pursuant to the Offer from each Qualifying Shareholder, taking into account the number of Shares which Wah Cheong has undertaken not to accept under the Offer, being approximately 14.23% (rounded down to the nearest whole number of Shares) of the Shares held by the relevant Qualifying Shareholder as shown on the Register at the close of the Offer assuming that no share